In these scholarly studies, 88 percent of topics with three months follow-up and 73 percent of these with half a year follow-up taken care of immediately the cells, displaying a post-treatment improvement in either FVC or ALSFRS-R, or both. .. BrainStorm presents excellent results from NurOwn phase 2a study in ALS in AAN annual meeting BrainStorm Cell Therapeutics Inc.C. Furthermore to previously disclosed topline outcomes, further data and analyses are being offered for the very first time today. Among the new outcomes can be a piecewise linear regression evaluation of most topics who received intrathecal administration in the stage 2a research and the last phase 1/2 research.The HR increased to 2.39 when the analysis was restricted to individuals who used only supplements, also to 2.70 after excluding MIs that occurred in the first 2 years of follow up. The group concludes: ‘This study suggests that increasing nutritional calcium intake from diet plan may not confer significant cardiovascular benefits, while calcium supplements, which might increase myocardial infarction risk, should be taken with caution.’ In an accompanying editorial, Ian Reid and Tag Bolland, from the University of Auckland in New Zealand, comment: ‘Calcium supplements have been widely embraced.